However, the overexpression of TRPC6 is linked to acquired glomerular diseases, and causative gain-of-function mutations in TRPC6 cause hereditary forms of focal segmental glomerulosclerosis (FSGS) [4,5]. Here, TRPC6 is linked to focal segmental glomerulosclerosis.